Thank you for donating!
You can donate using the following services.
Donate Today
Search
Need support today?
Email: info@npuk.org
Helpline: 0191 415 0693
Main menu
Niemann-Pick Diseases
About Us
Care & Support
Research
Fundraising
Resources
Blog
News
NPUK Shop
Cyclo Therapeutics Announces Design of Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
Posted: 27.04.21
NPUK
>
Clinical Trials
>
CTD Holdings Inc
>
Cyclo Therapeutics Announces Design of Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
Press on 301 Pivotal Design on ClinicalTrials Gov Apr27 2021
Donate today
Follow NPUK
Contact us
Donate today
Email: info@npuk.org
Helpline: 0191 415 0693